PROS1 and glioblastoma: Aiming to better understand whether iHDAC treatment could modulate the Core Matrisome, Matrisome-associated, ECM-affiliated proteins and Proteoglycans that underly the mechanisms involved in GBM angiogenesis, we went to characterize the GBM AngioMatrix (42).